A detailed history of Smartleaf Asset Management LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 185 shares of LGND stock, worth $21,941. This represents 0.0% of its overall portfolio holdings.

Number of Shares
185
Previous 197 6.09%
Holding current value
$21,941
Previous $16.2 Million 11.06%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$82.7 - $110.11 $992 - $1,321
-12 Reduced 6.09%
185 $18 Million
Q2 2024

Aug 13, 2024

BUY
$68.53 - $87.91 $13,500 - $17,318
197 New
197 $16.2 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $2B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.